Ishrak: Medtronic has eyes on overseas acquisitions

Medtronic ($MDT) is eyeing overseas acquisitions and has roughly $2 billion a year to spend, said Omar Ishrak at the J.P. Morgan Healthcare Conference in San Francisco, Bloomberg notes. However, "[w]e need to have a far more disciplined approach to acquisitions," said Ishrak. "That may be tough, but we'll have to find a way to do it. It's going to be a big hurdle to get any form of dilution from us." News

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.